![](https://i0.wp.com/glhf.org/wp-content/uploads/2021/09/Gene-Therapy-2-re-sized.jpg?resize=668%2C335&ssl=1)
Update from BioMarin Phase 3 Trial
BioMarin’s investigational gene therapy for hemophilia A has not been approved for use; clinical trials are ongoing.
Please click this link to read an update from BioMarin on a phase 3 trial.
Source: National Hemophilia Foundation